Repurposed Antimicrobial Combination Therapy: Tobramycin-Ciprofloxacin Hybrid Augments Activity of the Anticancer Drug Mitomycin C Against Multidrug-Resistant Gram-Negative Bacteria
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repurposed Antimicrobial Combination Therapy: Tobramycin-Ciprofloxacin Hybrid Augments Activity of the Anticancer Drug Mitomycin C Against Multidrug-Resistant Gram-Negative Bacteria
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-07-10
DOI
10.3389/fmicb.2019.01556
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using human experience to identify drug repurposing opportunities: theory and practice
- (2019) D. Cavalla BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant Acinetobacter baumannii
- (2019) Yu-Shan Cheng et al. Frontiers in Cellular and Infection Microbiology
- Drug combinations: a strategy to extend the life of antibiotics in the 21st century
- (2019) Mike Tyers et al. NATURE REVIEWS MICROBIOLOGY
- Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria
- (2019) Kaitlyn E. Kortright et al. Cell Host & Microbe
- The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli
- (2019) Ronald Domalaon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Short Proline-Rich Lipopeptide Potentiates Minocycline and Rifampin against Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa
- (2018) Ronald Domalaon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
- (2018) Ronald Domalaon et al. CLINICAL MICROBIOLOGY REVIEWS
- The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions
- (2018) Prasanthi Polamreddy et al. DRUG DISCOVERY TODAY
- Infections by multidrug-resistant Gram-negative Bacteria: what's new in our arsenal and what's in the pipeline?
- (2018) Despoina Koulenti et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Potential for repurposing the personal care product preservatives bronopol and bronidox as broad-spectrum antibiofilm agents for topical application
- (2018) Victoria E Lee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- An update on Drug Repurposing: Re-written saga of the drug’s fate
- (2018) Hema Sree GNS et al. BIOMEDICINE & PHARMACOTHERAPY
- Repurposing the anticancer drug mitomycin C for the treatment of persistent Acinetobacter baumannii infections
- (2017) Martha Yumiko Cruz-Muñiz et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A Tobramycin Vector Enhances Synergy and Efficacy of Efflux Pump Inhibitors against Multidrug-Resistant Gram-Negative Bacteria
- (2017) Xuan Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Amphiphilic Tobramycin–Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline
- (2017) Yinfeng Lyu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
- (2017) Seth W. Dickey et al. NATURE REVIEWS DRUG DISCOVERY
- Polymyxin B3–Tobramycin Hybrids with Pseudomonas aeruginosa-Selective Antibacterial Activity and Strong Potentiation of Rifampicin, Minocycline, and Vancomycin
- (2017) Ronald Domalaon et al. ACS Infectious Diseases
- ABC transporters as mediators of drug resistance and contributors to cancer cell biology
- (2016) Jamie I. Fletcher et al. DRUG RESISTANCE UPDATES
- Hybrid Antibiotic Overcomes Resistance in P. aeruginosa by Enhancing Outer Membrane Penetration and Reducing Efflux
- (2016) Bala Kishan Gorityala et al. JOURNAL OF MEDICINAL CHEMISTRY
- Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications
- (2016) Katherine H. Luepke et al. PHARMACOTHERAPY
- Adjuvants Based on Hybrid Antibiotics Overcome Resistance in Pseudomonas aeruginosa and Enhance Fluoroquinolone Efficacy
- (2015) Bala Kishan Gorityala et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Combatting bacterial infections by killing persister cells with mitomycin C
- (2015) Brian W. Kwan et al. ENVIRONMENTAL MICROBIOLOGY
- Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections
- (2015) Adrián Rangel-Vega et al. Frontiers in Microbiology
- Probing the Penetration of Antimicrobial Polymyxin Lipopeptides into Gram-Negative Bacteria
- (2014) Zakuan Z. Deris et al. BIOCONJUGATE CHEMISTRY
- ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
- (2014) Young Choi et al. CURRENT PHARMACEUTICAL DESIGN
- A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity
- (2013) Zakuan Z Deris et al. JOURNAL OF ANTIBIOTICS
- Introduction to the CANWARD study (2007-11)
- (2013) D. J. Hoban et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibiotic adjuvants: multicomponent anti-infective strategies
- (2011) Lindsay Kalan et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started